tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Fischbeck, 28 are a SELL (19.18%), 84 are a BUY (57.53%), 34 are a HOLD (23.29%).
Analyst Kevin Fischbeck, currently employed at BAML, carries an average stock price target met ratio of 72.84% that have a potential upside of 20.71% achieved within 227 days.
Kevin Fischbeck’s has documented 300 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCA, HCA Holdings at 27-Jan-2025.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for UHS (UNIVERSAL HEALTH SERVICES) at 3/23/2020. The price target of $104 was fulfilled within 16 days with a profit of $33.53 (47.58%) receiving and performance score of 29.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2.25
$-1.17 (-34.21%)
$1.75
1 months 11 days ago
(10-Jan-2025)
2/3 (66.67%)
$-0.18 (-7.41%)
17
Buy
$3
$-0.42 (-12.28%)
$8
3 months 2 days ago
(19-Nov-2024)
1/6 (16.67%)
$1.41 (88.68%)
59
Hold
$2
$-1.42 (-41.52%)
$6.5
3 months 10 days ago
(11-Nov-2024)
2/4 (50%)
$-0.16 (-7.41%)
51
Hold
$18
3 months 10 days ago
(11-Nov-2024)
0/1 (0%)
$6.89 (62.02%)
Hold
$4
$0.58 (16.96%)
$7
4 months 13 days ago
(08-Oct-2024)
2/4 (50%)
$0.85 (26.98%)
7
Which stock is Kevin Fischbeck is most bullish on?
Which stock is Kevin Fischbeck is most reserved on?
What Year was the first public recommendation made by Kevin Fischbeck?
